Biosimilars have become an increasingly important part of modern biologic therapy, providing treatment options that are highly similar to established reference products while potentially improving access and reducing healthcare costs. Unlike conventional generic drugs, biosimilars are complex biological products that must undergo extensive analytical, pharmacokinetic, immunogenicity, and clinical evaluation before approval. In the field of […]